26 research outputs found

    Sensory characteristics and sterilization value of unpeeled whole tomato in juice

    Get PDF
    Makanjuola Solomon Akinremi1, Akanbi Charles Taiwo1, Enujiugha Victor Ndigwe2(1. Department of Food Science and Technology, Obafemi Awolowo University, Ile-Ife, Nigeria; 2. Department of Food Science and Technology, Federal University of Technology, Akure, Nigeria) Abstract: The sensory quality of unpeeled whole tomato (Lycopersicon esculentum var. Roma VF) packed in tomato juice with or without calcium chloride (CaCl2) was investigated.  Thermal process lethality for unpeeled whole tomato in CaCl2 juice was also determined.  Hermetically packaged tomatoes in tomato juice containing CaCl2 were preferred (P < 0.05) in terms of aroma and appearance.  Results revealed that D-value of Bacillus coagulans at 100℃ in jars of whole tomato in juice was 2.8 min and a lethal treatment equivalent to IS11.5100 = 12.7 min was safe from a spoilage standpoint for the unpeeled whole tomatoes in CaCl2 tomato juice (with a pH of 4.1 or less) in the ratio of 7:9.  Converted to experimental times, this lethality was achieved with a 22 minutes thermal processing in steam at 100℃ for a 370 mL jar used in this investigation.Keywords: unpeeled whole tomato, sensory quality, calcium chloride, thermal process lethality, integrated sterilization value Citation: Makanjuola Solomon Akinremi,  Akanbi Charles Taiwo, Enujiugha Victor Ndigwe.  Sensory characteristics and sterilization value of unpeeled whole tomato in juice.  Agric Eng Int: CIGR Journal, 2010, 12(2): 117-123. &nbsp

    Colour and Fatty Acids Analysis of Fermented and Canned African Oil Bean (Pentaclethra macrophylla Benth) Seeds

    Get PDF
    The variations in the colour and fatty acid profiles as influenced by the processing steps and changes in canning media during thermal processing of fermented African oil bean (Pentaclethra macrophylla Benth) seeds were investigated. The seed cotyledons were prepared as slices and fermented at 30oC for 72 h. The fermented product was then filled into cans containing the selected media and processed using conventional canning procedures. Cooking and canning steps slightly darkened the light brown colour of the cotyledons. However, overall, thermal processing did not significantly (p > 0.05) affect the colour profile of the fermented seed product ‘ugba’ as shown from a*/b* ratios, hue and chroma values. Although fermentation significantly (p > 0.05) affected the composition and concentrations of fatty acids in the seed oil, the effect of canning of the fermented seed product in three different media (tomato sauce, refined groundnut oil and brine solution) on the fatty acid profiles of the seed oil was not significant (p > 0.05). Linoleic acid, which was the major fatty acid in the raw seed oil (67.20 wt.-% of total fatty acids), increased significantly during fermentation, but further thermal processing in lacquered cans did not affect the fatty acids profile. Keywords: Oil bean seed; fermented product; thermal processing; colour; fatty acid

    Self‑reported Training Needs among Physicians in a Tertiary Institution, Southwest, Nigeria: An Application of Hennessy‑Hicks Training Needs Assessment Tool

    Get PDF
    Background: To keep pace with existing as well as emerging public and population health challenges, continuing in‑service professionaldevelopment (CPD) of physicians is paramount. This study assessed the training needs of physicians in a tertiary hospital in Ibadan, South‑West,Nigeria. Methods: This study utilized a descriptive cross‑sectional design. Three hundred and fifty‑five physicians were randomly selected. Data were collected with the aid of the Hennessy‑Hicks Training Needs Assessment tool. The instrument has five broad sub‑sections: Research/audit, communication/teamwork, clinical tasks, administration, and management/supervisory tasks. In all, these subsections are made up of 30 items with their roles/tasks and were used to assess the training needs of individual study respondents. Charts and proportions were utilized to present the CPD training needs reported by physicians. Mann–Whitney U test was used to examine the difference in training needs between consultants and resident doctors.  Results: A larger proportion of the study respondents were middle‑aged adults. Respondents’ ages were fairly distributed across the varying age brackets. Respondents within the age bracket 35–39 were the highest (30.36%), followed by those within ages 30–34 years (24.09%). With regard to training needs and capacity development, research/audit skills had the highest need (0.83). Furthermore, training that enhances   managerial/supervisory skills had a rating of 0.68. Clinical tasks and administration tasks have the same rating (0.63), whereas   communication/teamwork had the lowest rating. Consultants expressed higher training needs compared with resident doctors across all task domains. Conclusion: Quest for skills in research had the topmost priority among physicians, and thus, majority were likely to be receptive to training and acquisition of new skills. Future CPD training should reflect the critical needs for performance improvement, as indicated in this study. Keywords: Continuing Professional Development, Health-care, Hennessy‑Hicks Training Needs Assessment, Physicians, Nigeri

    findings from the World Health Organization World Mental Health surveys

    Get PDF
    Funding Information: The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the United States National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. The Argentina survey—Estudio Argentino de Epidemiología en Salud Mental (EASM)— was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Nación). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204–3. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD surveys were funded by the European Commission (contracts QLG5–1999-01042; SANCO 2004123 and EAHC 20081308), the Piedmont Region, Italy, Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000– 158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP) and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through the United Nations Development Group Iraq Trust Fund (UNDG ITF). The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (R03 TW006481–01), anonymous private donations to IDRAAC, Lebanon and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfizer, Phenicia, Servier, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: the New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council and the Health Research Council. The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria) and the Federal Ministry of Health, Abuja, Nigeria. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects ‘Policies in Mental Health Area’ and ‘National Study regarding Mental Health and Services Use’ were carried out by the National School of Public Health and Health Services Management (former National Institute for Research and Development in Health, present National School of Public Health Management and Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics—National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands and were funded by the Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; grant 044708) and the John W. Alden Trust. None of the funders had any role in the design, analysis, interpretation of results or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the World Health Organization, other sponsoring organizations, agencies or governments. J.J.M. received the John Cade Fellowship APP1056929 from the National Health and Medical Research Council and the Niels Bohr Professorship from the Danish National Research Foundation. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med. harvard.edu/wmh/. Publisher Copyright: © 2017 Society for the Study of AddictionBackground and aims: Prior research has found bidirectional associations between psychotic experiences (PEs) and selected substance use disorders. We aimed to extend this research by examining the bidirectional association between PEs and various types of substance use (SU) and substance use disorders (SUDs), and the influence of antecedent mental disorders on these associations. Design, setting, participants and measurements: We used data from the World Health Organization World Mental Health surveys. A total of 30 902 adult respondents across 18 countries were assessed for (a) six types of life-time PEs, (b) a range of types of SU and DSM-IV SUDs and (c) mental disorders using the Composite International Diagnostic Interview. Discrete-time survival analyses based on retrospective age-at-onset reports examined the bidirectional associations between PEs and SU/SUDs controlling for antecedent mental disorders. Findings: After adjusting for demographics, comorbid SU/SUDs and antecedent mental disorders, those with prior alcohol use disorders [odds ratio (OR) = 1.6, 95% confidence interval (CI) = 1.2–2.0], extra-medical prescription drug use (OR = 1.5, 95% CI = 1.1–1.9), alcohol use (OR = 1.4, 95% CI = 1.1–1.7) and tobacco use (OR = 1.3, 95% CI = 1.0–1.8) had increased odds of subsequent first onset of PEs. In contrast, those with temporally prior PEs had increased odds of subsequent onset of tobacco use (OR = 1.5, 95% CI = 1.2–1.9), alcohol use (OR = 1.3, 95% CI = 1.1–1.6) or cannabis use (OR = 1.3, 95% CI = 1.0–1.5) as well as of all substance use disorders (ORs ranged between 1.4 and 1.5). There was a dose response relationship between both count and frequency of PEs and increased subsequent odds of selected SU/SUDs. Conclusions: Associations between psychotic experiences (PEs) and substance use/substance use disorders (SU/SUDs) are often bidirectional, but not all types of SU/SUDs are associated with PEs. These findings suggest that it is important to be aware of the presence of PEs within those with SUDs or at risk of SUDs, given the plausibility that they may each impact upon the other.publishersversionpublishe

    Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys

    Get PDF
    Patient-reported helpfulness of treatment is an important indicator of quality in patient-centered care. We examined its pathways and predictors among respondents to household surveys who reported ever receiving treatment for major depression, generalized anxiety disorder, social phobia, specific phobia, post-traumatic stress disorder, bipolar disorder, or alcohol use disorder. Data came from 30 community epidemiological surveys - 17 in high-income countries (HICs) and 13 in low- and middle-income countries (LMICs) - carried out as part of the World Health Organization (WHO)'s World Mental Health (WMH) Surveys. Respondents were asked whether treatment of each disorder was ever helpful and, if so, the number of professionals seen before receiving helpful treatment. Across all surveys and diagnostic categories, 26.1% of patients (N=10,035) reported being helped by the very first professional they saw. Persisting to a second professional after a first unhelpful treatment brought the cumulative probability of receiving helpful treatment to 51.2%. If patients persisted with up through eight professionals, the cumulative probability rose to 90.6%. However, only an estimated 22.8% of patients would have persisted in seeing these many professionals after repeatedly receiving treatments they considered not helpful. Although the proportion of individuals with disorders who sought treatment was higher and they were more persistent in HICs than LMICs, proportional helpfulness among treated cases was no different between HICs and LMICs. A wide range of predictors of perceived treatment helpfulness were found, some of them consistent across diagnostic categories and others unique to specific disorders. These results provide novel information about patient evaluations of treatment across diagnoses and countries varying in income level, and suggest that a critical issue in improving the quality of care for mental disorders should be fostering persistence in professional help-seeking if earlier treatments are not helpful

    Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

    Get PDF
    Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

    Pain management in sickle cell disease: What remedy to reduce the risk of opioid abuse?

    No full text
    Sickle cell disease is an inherited disorder, the hallmark of which is recurrent acute painful crises requiring opioid therapy. These acute painful episodes when superimposed on chronic pain could last for years especially in association with comorbidities like osteonecrosis, chronic leg ulcers, cholelithiasis or stuttering priapism. The need for adequate pain control in such patients should therefore be balanced to avoid opioid dependence. The treatment of superimposed acute pain with opioid in a patient with background chronic pain makes pain control a challenge. This is because the comorbidities responsible for the chronic pain are often associated with a depressive state because of limited treatment options for some of these comorbidities. Abuse of opioid by a patient with chronic pain raises the possibility of pseudoaddiction. However, abuse of opioid is not limited to patients with chronic pain or acute on chronic pain, it has also being observed in patients without chronic pain. It is necessary to decide on drugs that may adequately control chronic pain on a long term with minimal side effects; the newer drugs on the horizon which are targeted towards sickle cell disease are therefore possible viable options.Keywords: Opioid, addiction, sickle cell pain, chronic pain, psychosocial, targeted therap
    corecore